Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

NCT00006136 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT00006136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
Lead sponsor
Boston University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1999
Completion date
Not reported
Enrollment
15
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

beta-thalassemia